Medications
Most US adults with T2D meet criteria for GLP-RAs, SGLT2is
Most U.S. adults with type 2 diabetes (T2D) meet recommended criteria for use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is), but fewer than 10 percent use ...
Feb 28, 2023
0
3